scholarly journals Assessing the Cost-Effectiveness of using Aclidinium Bromide 400 µG /Formoterol Fumarate Dihydrate 12 µG Compared to Aclidinium Bromide 400 µG in the Management of Moderate to Severe Chronic Obstructive Pulmonary Disease

2015 ◽  
Vol 18 (7) ◽  
pp. A340 ◽  
Author(s):  
M Ramos ◽  
J Haughney ◽  
N Henry ◽  
L Lindner ◽  
M Lamotte
Keyword(s):  
Chronic Obstructive Pulmonary Disease ◽  
Cost Effectiveness ◽  
Pulmonary Disease ◽  
Chronic Obstructive ◽  
Obstructive Pulmonary Disease ◽  
Aclidinium Bromide ◽  
The Cost ◽  
Formoterol Fumarate

Evaluating the cost-effectiveness of combination inhalers for the management of chronic obstructive pulmonary disease

2020 ◽  
Vol 26 (9) ◽  
pp. 231-233
Author(s):  
Matthew Taylor ◽  
Michelle Green
Keyword(s):  
Chronic Obstructive Pulmonary Disease ◽  
Cost Effectiveness ◽  
Pulmonary Disease ◽  
Cost Effectiveness Analysis ◽  
Chronic Obstructive ◽  
Valuable Insight ◽  
Obstructive Pulmonary Disease ◽  
Effectiveness Analysis ◽  
The Cost ◽  
Insight Into

Matthew Taylor and Michelle Green provide a valuable insight into methods of vital cost-effectiveness analysis of combination inhalers for the management of chronic obstructive pulmonary disease.

The cost-effectiveness of antidepressants for smoking cessation in chronic obstructive pulmonary disease (COPD) patients

Addiction ◽  
2009 ◽  
Vol 104 (12) ◽  
pp. 2110-2117 ◽  
Author(s):  
Constant P. Van Schayck ◽  
Janneke Kaper ◽  
Edwin J. Wagena ◽  
Emiel F. M. Wouters ◽  
Johannes L. Severens
Keyword(s):  
Chronic Obstructive Pulmonary Disease ◽  
Smoking Cessation ◽  
Cost Effectiveness ◽  
Pulmonary Disease ◽  
Chronic Obstructive ◽  
Obstructive Pulmonary Disease ◽  
Copd Patients ◽  
The Cost
Sign in / Sign up

Export Citation Format

Share Document